Antimicrobial Resistance Determinants in Imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii Complex Isolated in Daejeon, Korea
2
조회
0
다운로드
8
인용
0
참고문헌
키워드
초록
Background: Members of the Acinetobacter calcoaceticus-baumannii (Acb) complex are important opportunistic bacterial pathogens and present significant therapeutic challenges in the treatment of nosocomial infections. In the present study, we investigated the integrons and various genes involved in resistance to carbapenems, aminoglycosides, and fluoroquinolones in 56 imipenem-nonsusceptible Acb complex isolates. Methods: This study included 44 imipenem-nonsusceptible A. baumannii, 10 Acinetobacter genomic species 3, and 2 Acinetobacter genomic species 13TU strains isolated in Daejeon, Korea. The minimum inhibitory concentrations (MICs) were determined by Etest. PCR and DNA sequencing were used to identify the genes that potentially contribute to each resistance phenotype. Results: All A. baumannii isolates harbored the blaOXA-51-like gene, and 21 isolates (47.7%) co-produced OXA-23. However, isolates of Acinetobacter genomic species 3 and 13TU only contained blaIMP-1 or blaVIM-2. Most Acb complex isolates (94.6%) harbored class 1 integrons, armA, and/or aminoglycoside-modifying enzymes (AMEs). Of particular note was the fact that armA and aph(3´)-Ia were only detected in A. baumannii isolates, which were highly resistant to amikacin (MIC50≥256) and gentamicin (MIC50≥1,024). In all 44 A. baumannii isolates, resistance to fluoroquinolones was conferred by sense mutations in the gyrA and parC. However, sense mutations in parC were not found in Acinetobacter genomic species 3 or 13TU isolates. Conclusions: Several differences in carbapenem, aminoglycoside, and fluoroquinolone resistance gene content were detected among Acb complex isolates. However, most Acb complex isolates (87.5%) possessed integrons, carbapenemases, AMEs, and mutations in gyrA. The co-occurrence of several resistance determinants may present a significant threat.
Abstract
Background: Members of the Acinetobacter calcoaceticus-baumannii (Acb) complex are important opportunistic bacterial pathogens and present significant therapeutic challenges in the treatment of nosocomial infections. In the present study, we investigated the integrons and various genes involved in resistance to carbapenems, aminoglycosides, and fluoroquinolones in 56 imipenem-nonsusceptible Acb complex isolates. Methods: This study included 44 imipenem-nonsusceptible A. baumannii, 10 Acinetobacter genomic species 3, and 2 Acinetobacter genomic species 13TU strains isolated in Daejeon, Korea. The minimum inhibitory concentrations (MICs) were determined by Etest. PCR and DNA sequencing were used to identify the genes that potentially contribute to each resistance phenotype. Results: All A. baumannii isolates harbored the blaOXA-51-like gene, and 21 isolates (47.7%) co-produced OXA-23. However, isolates of Acinetobacter genomic species 3 and 13TU only contained blaIMP-1 or blaVIM-2. Most Acb complex isolates (94.6%) harbored class 1 integrons, armA, and/or aminoglycoside-modifying enzymes (AMEs). Of particular note was the fact that armA and aph(3´)-Ia were only detected in A. baumannii isolates, which were highly resistant to amikacin (MIC50≥256) and gentamicin (MIC50≥1,024). In all 44 A. baumannii isolates, resistance to fluoroquinolones was conferred by sense mutations in the gyrA and parC. However, sense mutations in parC were not found in Acinetobacter genomic species 3 or 13TU isolates. Conclusions: Several differences in carbapenem, aminoglycoside, and fluoroquinolone resistance gene content were detected among Acb complex isolates. However, most Acb complex isolates (87.5%) possessed integrons, carbapenemases, AMEs, and mutations in gyrA. The co-occurrence of several resistance determinants may present a significant threat.
참고문헌 (28)
- Bergogne-Bérézin E, "Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features", Clin Microbiol Rev, 9, pp.148~165 (1996)
- La Scola B, "Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species", J Clin Microbiol, 44, pp.827~832 (2006)
- Gerner-Smidt P, "Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex", APMIS, 101, pp.826~832 (1993)
- van den Broek PJ, "Endemic and epidemic Acinetobacter species in a university hospital: an 8-year survey", J Clin Microbiol, 47, pp.3593~3599 (2009)
- Gootz TD, "Acinetobacter baumannii: an emerging multidrug-resistant threat", Expert Rev Anti Infect Ther, 6, pp.309~325 (2008)
- Poirel L, "Carbapenem resistance in Acinetobacter baumannii mechanisms and epidemiology", Clin Microbiol Infect, 12, pp.826~836 (2006)
- Poirel L, "Carbapenemases: molecular diversity and clinical consequences", Future Microbiol, 2, pp.501~512 (2007)
- Mugnier PD, "Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii", J Bacteriol, 191, pp.2414~2418 (2009)
- Petersen A, "Class I integrons containing a dhfrI trimethoprim resistance gene cassette in aquatic Acinetobacter spp", FEMS Microbiol Lett, 182, pp.73~76 (2000)
- Nemec A, "Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones", J Med Microbiol, 53, pp.1233~1240 (2004)
- Cho YJ, "Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 64, pp.185~190 (2009), ELSEVIER SCIENCES INC
- Vila J, "Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii", Antimicrob Agents Chemother, 39, pp.1201~1203 (1995)
- Gundi VA, "Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species", Microbiology, 155, pp.2333~2341 (2009)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing: twentieth informational supplement, M100-S20" (2010), Clinical and Laboratory Standards Institute
- 구선회, "Genetic Basis of Multidrug-resistant Acinetobacter baumannii Clinical Isolates from Three University Hospitals in Chungcheong Province, Korea", Annals of Laboratory Medicine, 30(5), pp.498~506 (2010), 대한진단검사의학회
- Akers KS, "Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex", J Clin Microbiol, 48, pp.1132~1138 (2010)
- Bogaerts P, "Emergence of ArmA and RmtB aminoglycoside resistance 16S rRNA methylases in Belgium", J Antimicrob Chemother, 59, pp.459~464 (2007)
- Mendes RE, "Rapid detection and identification of metallo-β-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis", J Clin Microbiol, 45, pp.544~547 (2007)
- 신소연, "Characteristics of aac(6′)-Ib-cr Gene in Extended-Spectrum b-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolated from Chungnam Area", Annals of Laboratory Medicine, 29(6), pp.541~550 (2009), 대한진단검사의학회
- Bou G, "PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii", Clin Microbiol Infect, 6, pp.635~643 (2000)
- Lee JH, "Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 59, pp.633~639 (2007), OXFORD UNIV PRESS
- Lee K, "Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea", International Journal Of Antimicrobial Agents, 33(6), pp.520~524 (2009)
- Turton JF, "The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii", FEMS Microbiol Lett, 258, pp.72~77 (2006)
- 성지연, "IMP-1과 OXA -lactamase를 생성하는 Carbapenem 내성 Acinetobacter baumanni 의 확산", Annals of Laboratory Medicine, 28(1), pp.16~23 (2008), 대한진단검사의학회
- Yum JH, "Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes", J Antimicrob Chemother, 49, pp.837~840 (2002)
- Zhou Y, "Distribution of 16S rRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides", Eur J Clin Microbiol Infect Dis, 29, pp.1349~1353 (2010)
- Akasaka T, "Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance", Antimicrob Agents Chemother, 45, pp.2263~2268 (2001)
- Valentine SC, "Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California", J Clin Microbiol, 46, pp.2499~2507 (2008)